Zepbound

Introduction Anxiety on Zepbound® is one of those side effects that doesn’t appear in the headline trial data but shows up consistently in patient…

Zepbound is tirzepatide, a once-weekly GLP-1/GIP dual agonist.

Introduction Fatigue ranks among the most reported off-label complaints from people starting Zepbound®, even though the official Eli Lilly label lists it as an…

Zepbound causes heartburn primarily through one mechanism: slowed gastric emptying. Tirzepatide delays how quickly food and acid leave the stomach.

UnitedHealthcare processes pharmacy benefits through OptumRx, so Zepbound denials come back as OptumRx adverse determinations.

Introduction Tricare denials for Zepbound® (tirzepatide) follow the same two-level appeal structure as other pharmacy denials, but the clinical arguments that win are specific…

Medicare denials for Zepbound are frustrating because the rules changed in late 2024 and most prescribers and pharmacists haven’t caught up.

Medicaid denials for Zepbound (tirzepatide) follow a predictable pattern, and the appeal follows a predictable counter-pattern.

Introduction Kaiser Permanente’s integrated HMO model means Zepbound® denials come from Kaiser’s internal Drug Coverage and Utilization Management committee, not from an outside PBM….